Class

For the last decade, Martin Woodbridge has worked with regulators, and industry and health professionals to promote the rational use of cannabis-based medicines. Here, he considers the introduction of cannabis-based medicines to New Zealand and explores what it means for pharmacy practice

Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model

This article, written by Cathy Stephenson, Alex Ker and Rachel Johnson, covers the diverse aspects of providing gender-affirming healthcare for Aotearoa’s transgender and non-binary people, including the use of puberty blockers and hormone therapy, as well as the general principles for pharmacists to be aware of

Dry eye disease affects a large number of people and causes a significant degree of morbidity. It can usually never be cured, but good management of the underlying causes can allow significant improvements in quality of life. Nick Mathew provides an overview of this common condition and its management in primary and secondary care

Māori attitudes to healthcare today are deeply rooted in New Zealand history. In this article, Deborah Bassett-Clarke discusses some reasons why the current model of pharmacy practice does not always meet the needs of Māori and may actually cause health inequities. Understanding these factors is an important first step to improving outcomes for Māori